CN109294974A - A kind of hybridized prussian carp myeloid tissue cell line and its construction method are applied with it - Google Patents

A kind of hybridized prussian carp myeloid tissue cell line and its construction method are applied with it Download PDF

Info

Publication number
CN109294974A
CN109294974A CN201811231823.XA CN201811231823A CN109294974A CN 109294974 A CN109294974 A CN 109294974A CN 201811231823 A CN201811231823 A CN 201811231823A CN 109294974 A CN109294974 A CN 109294974A
Authority
CN
China
Prior art keywords
culture
cell
carp
tissue
hybridized prussian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811231823.XA
Other languages
Chinese (zh)
Other versions
CN109294974B (en
Inventor
沈锦玉
曹铮
潘晓艺
夏焱春
姚嘉赟
蔺凌云
尹文林
刘忆瀚
陆裕肖
邢刚
岳丰雄
周涛
黄杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Institute of Freshwater Fisheries
Original Assignee
Chengdu Tecbond Biological Products Co ltd
Zhejiang Institute of Freshwater Fisheries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu Tecbond Biological Products Co ltd, Zhejiang Institute of Freshwater Fisheries filed Critical Chengdu Tecbond Biological Products Co ltd
Priority to CN201811231823.XA priority Critical patent/CN109294974B/en
Publication of CN109294974A publication Critical patent/CN109294974A/en
Application granted granted Critical
Publication of CN109294974B publication Critical patent/CN109294974B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0669Bone marrow stromal cells; Whole bone marrow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/705Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00Methods for the dissociation of cells, e.g. specific use of enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16051Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a kind of hybridized prussian carp myeloid tissue cell lines and its construction method to apply with it, cell line classification entitled hybridized prussian carp myeloid tissue cell line (Spinal cord tissue cell lines of Carassius auratus gibelio, CSC), deposit number is CCTCC NO:C2018211.Above-mentioned cell line can be applied in the vaccine of the separation of carp herpesvirusⅡtype, culture, detection and preparation carp herpesvirusⅡtype.The present invention provides necessary technology platform for the separation identification of CyHV-2 and its research of complete biological characteristics, has established important basis for the prevention and control of crucian Hematopoietic Necrosis disease.

Description

A kind of hybridized prussian carp myeloid tissue cell line and its construction method are applied with it
Technical field
The invention belongs to aquatile cell and technical field of aquiculture disease prevention, specifically, being related to a kind of different Pond crucian carp myeloid tissue cell line and its construction method is educated to apply with it.
Background technique
Carp herpesvirusⅡtype (Cyprinid herpesvirus II, CyHV-2) is otherwise known as simplex keratitis hematopoiesis Organ necrosis disease viral (Herpesviral haematopoietic necrosis virus, HVHNV) or goldfish blood forming organ Necrosis virus (Goldfish haematopoietic necrosis virus, GFHNV), other two kinds of blisters with cyprinid fish Exanthema virus CyHV-1 (Carp pox) and CyHV-3 (Koi herpesvirus, KHV) belong to Alloherpesviridae section, Cypriniviruse belongs to.CyHV-2 is reported for the first time in nineteen ninety-five, and the goldfish cultivated between 1992~1993 years to western Japan is made At huge economic loss, the illness goldfish death rate is up to 100%.Subsequent other countries and area also have the disease to break out in succession Report, there is mortality in the goldfish juvenile fish of the circulating water cultivation of U.S.West Coast one in spring in 1997, and the death rate is up to 80% or more, after be proved to be and infected by CyHV-2.The whole world that the international trade of ornamental fish has greatly facilitated the disease passes It broadcasts, the goldfish that subsequent China Taiwan, Australia, Britain cultivate breaks out the disease in succession.Hungary reports cultivation within 2011 Pond crucian carp has also discovered CyHV-2 infection.From 2009, in China, the main culture zone Jiangsu Province of crucian has been broken out is drawn by CyHV-2 The crucian Hematopoietic Necrosis's disease risen, by mid-September, 2018, in Jiangsu Province the ground such as the shining sun, great Feng, Baoying County, Gaoyou, East Platform Disease occurring area is more than 100,000 mu, and the death rate on the morbidity pool mouthful is up to 90%, caused by economic loss reached several hundred million members.With this Meanwhile in provinces such as Hubei, Hunan, Jiangxi, Zhejiang, also go out CyHV-2 in illness crucian vivo detection in succession.The viral infection Property it is strong, lethality is high, to crucian cultivation industry cause weight huge economic loss, seriously threaten the sound development of the industry.
Cell culture isolation technics is most accurate virus diagnostic method, usually World Organization for Animal Health (OIE) The prefered method of the fishes virus detection of recommendation.But existing research discovery CyHV-2 is difficult to separate common cell in fishes virus It is proliferated in system.Fat head carp cell (fathead minnow cells, FHM), carp epithelium oncocyte (epithelioma Popuasum cuprini, EPC), grass carp gonad cell (grass carp ovary, CO), grass carp nephrocyte (grass carp Kidney, CIK) it is insensitive to CyHV-2, only fancy carp fin cell (koi fin1, KF-1) can generate cytopathic effect (CPE), but virus is after KF-1 cell was uploaded to for the 3rd~5 generation, and CPE disappears and can't detect viral nucleic acid.Although having been established Hybridized prussian carp brain tissue cell system and sensitive to CyHV-2, but since inventor does not supply externally, also it is a lack of CyHV-2 sensitivity Cell line, limit the research to CyHV-2, therefore establish the cell line sensitive to CyHV-2 and study the life of the cell line Object characteristic carries out continuous passage to CyHV-2 and expands culture to further investigate the characteristic of virus, has great importance.
Summary of the invention
It is applied in view of this, the present invention provides a kind of hybridized prussian carp myeloid tissue cell lines and its construction method with it, The cell line can be used for separating, detect and cultivate carp herpesvirusⅡtype;For carrying out serial passages in vitro to CyHV-2, expanding Big culture is to further investigate the characteristic of the virus.
In order to solve the above-mentioned technical problem, the invention discloses a kind of hybridized prussian carp myeloid tissue cell line (Spinal Cord tissue cell lines of Carassius auratus gibelio, CSC), deposit number is CCTCC NO: C2018211。
The invention also discloses a kind of construction methods of above-mentioned hybridized prussian carp myeloid tissue cell line, including following step It is rapid:
The processing of step 1, myeloid tissue: under aseptic condition take out hybridized prussian carp myeloid tissue, aseptic process be 30~ 60mm3Tissue block, be put into the culture dish of the culture solution containing L15;
Step 2, originally culture: the tissue block in step 1 is equably put into T25 Tissue Culture Flask, tissue block is put On one side upward, 3ml culture solution is added in culture bottle slowly culture bottle side comes overnight, tissue block is made to infiltrate culture solution, then Upward by the one side of organized block, during which irregularly operation is once up to organizing block edge to grow cell, just by Tissue Culture Flask Culture is set, replacement culture solution is primary within every 2~3 days;
Step 3, secondary culture: after originally culture hybridized prussian carp myeloid tissue cell grows up to single layer, trypsase is added and disappears Change liquid and stand digestion 1~2 minute, hanged cell with culture solution, carries out secondary culture in such a way that 1 bottle passes 2 bottles, again to cell After forming single layer, secondary culture next time is carried out according to the secondary culture method of above-mentioned cell, obtains a kind of hybridized prussian carp ridge The cell line CSC of myeloid tissue.
Optionally, the hybridized prussian carp myeloid tissue cell L15 culture solution in the step 1 is to contain 10~20%V/V Fetal calf serum, 100U/ml penicillin, 100 μ g/ml streptomysins, the culture solution of pH value 7.0~7.4.
Optionally, the tryptic digestive juice of the cell passage in the step 3 is 0.25%W/V trypsase- EDTA digestive juice.
Optionally, the cell culture in step 2 and step 3, passage temperature be 23~25 DEG C, pH value 7.0~7.4.
The invention also discloses a kind of above-mentioned hybridized prussian carp myeloid tissue cell lines in the separation of carp herpesvirusⅡtype, training Application in supporting and detecting.
Optionally, the carp herpesvirusⅡtype is carp herpesvirusⅡtype separation strains.
The invention also discloses a kind of above-mentioned hybridized prussian carp myeloid tissue cell lines in preparation carp herpesvirusⅡtype Application in vaccine.
Optionally, the carp herpesvirusⅡtype is carp herpesvirusⅡtype separation strains.
Compared with prior art, the present invention can be obtained including following technical effect:
1) existing research discovery CyHV-2 is difficult to separate in common cell line in fishes virus and is proliferated.Fat head carp is thin Born of the same parents (fathead minnow cells, FHM), grass carp gonad cell (grass carp ovary, CO), carp epithelium oncocyte (epithelioma popuasum cuprini, EPC), grass carp nephrocyte (grass carp kidney, CIK) are to CyHV- 2 is insensitive, and only fancy carp fin cell (koi fin1, KF-1) can generate cytopathic effect (CPE), but virus is on KF-1 cell After reaching for the 3rd~5 generation, CPE disappears and can't detect viral nucleic acid.And the present invention is susceptible to CyHV-2 different using being separately cultured The myeloid tissue's cell for educating pond crucian carp establishes the hybridized prussian carp myeloid tissue cell line sensitive to CyHV-2.
2) present invention detects verifying to the carp herpesvirusⅡtype DNA for carrying out continuous passage on CSC cell, as a result confirms Viral nucleic acid still can be detected in the 10th generation of CSC cell continuous passage;Cytopathic effect (CPE) is stable and obvious;To occur The cell of pathological effect does ultra-thin electron microscopic section observation, and transmission electron microscope results are shown, there are the mature diseases of CyHV-2 in CSC cell Virion and its reproduction process, it was demonstrated that CyHV-2 has good biological activity in CSC cell.
3) present invention establishes CyHV-2 sensitive cell line based on the separation, detection and culture of carp herpesvirusⅡtype CSC provides necessary technology platform for the separation identification of CyHV-2 and its research of complete biological characteristics, makes for crucian Important basis has been established in the prevention and control of blood organ necrosis disease.
4) application of the cell line CSC that the present invention establishes, the cell line further include but are not limited to: for being separately cultured carp Application in herpesvirusⅡtype, detection and vaccine research and development, carries out carp herpesvirusⅡtype route of infection, sense on cell and level Contaminate mechanism, pathogenic mechanism etc..
Certainly, it implements any of the products of the present invention it is not absolutely required to while reaching all the above technical effect.
Detailed description of the invention
The drawings described herein are used to provide a further understanding of the present invention, constitutes a part of the invention, this hair Bright illustrative embodiments and their description are used to explain the present invention, and are not constituted improper limitations of the present invention.In the accompanying drawings:
Fig. 1 is different generation hybridized prussian carps myeloid tissue of the invention cell CSC schematic diagram;Wherein, a is primary hybridized prussian carp Myeloid tissue's cell, b are the 3rd generation hybridized prussian carp myeloid tissue cell line;
Fig. 2 is the chromosome of the 26th generation hybridized prussian carp myeloid tissue cell line of the invention;
Fig. 3 is schematic diagram after hybridized prussian carp myeloid tissue of the present invention cell line infection CyHV-2;Wherein, a is normal cell, B is the 4th day cell after infection, and c is the 6th day cell after infection.
Fig. 4 is the PCR testing result schematic diagram of different culture generation CyHV-2 of the invention;Wherein, M:100bp Marker; 1: 2nd generation CSC cell culture CyHV-2 cell toxicant;2: the 3 generation CSC cell culture CyHV-2 cell toxicants;3: the 4 generation CSC cells Cultivate CyHV-2 cell toxicant;4: the 5 generation CSC cell culture CyHV-2 cell toxicants;5: the 6 generation CSC cell culture CyHV-2 cells Poison;6: the 7 generation CSC cell culture CyHV-2 cell toxicants;7:CSC cell controls;8: negative control;9:CyHV-2 positive control;
Fig. 5 is the cell Electronic Speculum ultra-thin section schematic diagram of the 7th generation CyHV-2 cell toxicant infection CSC of the invention.
Specific embodiment
Carry out the embodiment that the present invention will be described in detail below in conjunction with embodiment, whereby to the present invention how application technology hand Section solves technical problem and reaches the realization process of technical effect to fully understand and implement.
Agents useful for same of the embodiment of the present invention is purchased from biochemical shop if not otherwise specified;Experimental technique used, it is such as not special It does not mentionlet alone bright, is routine techniques.
Material involved in the specific embodiment of the invention and reagent:
1) fish and strain are tested
Hybridized prussian carp, weight about 100~140g, body are about 17~20cm, try from Zhejiang Institute of Fresh Water Aquatic Products Test base.It is temporarily supported 1 week before experiment in indoor.Carp herpesvirusⅡtype is separated by this laboratory and is saved.
2) main agents and consumptive material
L15 cell culture medium, penicillin/streptomycin, phosphate buffer (PBS), trypsase-EDTA, dimethyl sulfoxide (DMSO), colchicine is purchased from Sigma company;Fetal calf serum is purchased from GIBICO company;DNAzol nucleic acid extracting reagent is Invitrogen product;PCR is TaKaRa Products with rTaq enzyme, dNTPs.Tissue Culture Flask, pipette, cell cryopreservation tube It is purchased from Corning company;Reagent needed for preparing transmission electron microscope ultra-thin section and consumptive material are purchased from Beijing Zhong Xing Berry company.
3) key instrument equipment
II grades of Biohazard Safety Equipments (Hfsafe-4B2);Inverted microscope (Nikon);Constant incubator (Sanyo, MIR- 153);CCD camera (Nikon NIS Elements F530);Low speed refrigerated centrifuge (EPPENDORF, 5424R);Ultralow temperature Refrigerator (MDF-382E);Liquid nitrogen container (TYD-35-125);Ultramicrotome (UC7, Leica);Transmission electron microscope (H- 7650, Hitachi).
Embodiment 1
The foundation of hybridized prussian carp myeloid tissue cell line, its step are as follows:
(1) processing of myeloid tissue: taking out hybridized prussian carp myeloid tissue under aseptic condition, aseptic process is 30~60mm3 Tissue block, be put into the culture dish of the culture solution containing L15;
(2) originally culture: the tissue block in step (1) is equably put into T25 Tissue Culture Flask, the one of tissue block is put Up, 3ml culture solution is added in culture bottle slowly culture bottle side comes overnight, so that tissue block is infiltrated culture solution, then will The one side of organized block upward, during which irregularly just setting Tissue Culture Flask once up to organizing block edge to grow cell by operation Culture, replacement culture solution is primary within every 2~3 days;The form of primary cell and passage cell is as shown in Figure 1.
(3) after originally culture hybridized prussian carp myeloid tissue cell grows up to single layer, the pancreas of 0.25%W/V secondary culture: is added Protease-EDTA digestive juice stands digestion 1~2 minute, has hanged cell with culture solution, carries out passage training in such a way that 1 bottle passes 2 bottles It supports, after cell forms single layer again, carries out secondary culture next time according to the secondary culture method of above-mentioned cell, obtain one The cell line CSC of kind hybridized prussian carp myeloid tissue;
Wherein, the tryptic digestive juice of passage is 0.25%W/V trypsase-EDTA digestive juice, cell culture, biography The temperature in generation is 23~25 DEG C, pH value 7.0~7.4;The hybridized prussian carp myeloid tissue cell culture fluid be containing 10~ 20%V/V fetal calf serum, 100U/ml penicillin, 100 μ g/ml streptomysins, the L15 culture solution of pH value 7.0~7.4.
Above-mentioned construction method method is simple, easy.
The cell line has been committed to China typical culture collection center on September 28th, 2018 and has carried out preservation, and preservation is compiled Number: CCTCC NO:C2018211, classification naming: hybridized prussian carp myeloid tissue cell line (Spinal cord tissue cell Lines of Carassius auratus gibelio, CSC), address: Wuhan, China Wuhan University.
Embodiment 2
The biological characteristics of hybridized prussian carp myeloid tissue cell line CSC:
(1) morphology: cell type is fibroblast-like cells.
(2) growth characteristics: start after the CSC cell 30min of passage it is adherent, after 6h it is adherent completely;Population doubling time is 48h。
(3) stability: reaching for 42 generations before hybridized prussian carp myeloid tissue cell line CSC to the applying date, proliferation is stablized.
(4) it freezes and recovers:
Adherent quick after CSC cell recovery, growthform, situation and the cell not frozen are substantially similar, do not occur bright Significant difference is other.Recovery cell Trypan Blue, counts through Cell counts, and the cell of about (78.56 ± 6.10) % is not colored, has Cell activity.
(5) chromosome analysis
26th generation hybridized prussian carp myeloid tissue cell line CSC is in logarithmic growth phase, and the autumn of final concentration of 20 μ g/ml is added Narcissus is plain, and cell is collected in digestion after 25 DEG C of incubation 4h, is pre-chilled with being added after the KCl solution Hypotonic treatment 25min of 0.075mol/L Kano fixer, 1000rpm centrifugation 5min goes after supernatant to be fixed 3 times with the Kano fixer being pre-chilled again, each 15min.It is cold It drips piece method and drips piece, dye 25min, micro- sem observation after drying with 5%Giemsa after drying.It is thin in 100 split coil methods of observation In born of the same parents, the chromosome number of the 26th generation hybridized prussian carp myeloid tissue derived cell is 156 articles (Fig. 2), with triploid hybridized prussian carp Karyological character coincide, i.e. whole chromosomes of hybridized prussian carp triploid 156, the chromosome without external source carp.
Embodiment 3
The application of hybridized prussian carp myeloid tissue cell line, process are as follows:
(1) acquisition and processing of carp herpesvirusⅡtype pathological material of disease are infected:
The just dead sick fish kidney, spleen and brain, myeloid tissue for infecting carp herpesvirusⅡtype of acquisition, shred and add etc. Volume PBS is homogenized, and sterile tissue homogenate is prepared into through 0.22 μm of membrane filtration after 5000rpm4 DEG C of centrifugation 15min, after packing Be stored in -80 DEG C it is spare;
(2) proliferation of the carp herpesvirusⅡtype in CSC:
CSC is cultivated to cell monolayer about 80%, discards culture medium after the cell maintenance medium of serum-free cleans 2 times, will Above-mentioned processed pathological material of disease tissue homogenate supernatant 0.2ml is inoculated in CSC cell monolayer, 24 DEG C of absorption 1h, during which every 15~ 20min weak vibrations culture bottle is once so as to uniform adsorption.After to be adsorbed, change serum-concentration be 2% L15 maintaining liquid after Continuous 24 DEG C of cultures, observe cytopathy (CPE) day by day, until lesion is up to harvest virus after 80%, which is carp herpesviral II The source of type separation strains.
(3) extraction of carp herpesvirusⅡtype cell toxicant nucleic acid and PCR detection:
Viral DNA will be extracted through DNAzol after CSC cell multigelation 2 times that obvious lesion occur.It is detected using PCR The method of CyHV-2 detects the virus.PCR amplification primer
CyHV2-366F are as follows: GGACTTGCGAAGAGTTTGATTTCTAC;
CyHV2-366R are as follows: CCATAGTCACCATCGTCTCATC;
Take amplification condition are as follows: 94 DEG C initial denaturation 5 minutes, 94 DEG C be denaturalized 30 seconds, 60 DEG C anneal 30 seconds, 72 DEG C extend 30 seconds, 72 DEG C 5 minutes after 35 circulations.
It takes positive control dna template to do positive control simultaneously, CSC cell DNA and pure water is taken to do negative control respectively.Amplification Product is identified through 2% (W/V) agarose gel electrophoresis.
(4) the Electronic Speculum observation of carp herpesvirusⅡtype infection CSC
The cytotoxic CSC cell of the 7th generation CyHV-2 will be infected after 2% glutaraldehyde is fixed, osmium tetroxide is fixed again, then is passed through Ultra-thin section is carried out after dehydration embedding, after the double dyeing of acetic acid uranium-lead citrate, transmission electron microscope observing.
(5) result
The homogenate inoculation of carp herpesvirusⅡtype disease fish tissues with CSC cell monolayer 4d after occur cell rounding or vacuolation, Pyknosis, formation plasomidum, space between cells become larger;After 6d CSC cell fusion and form multinucleate giant cell, cell monolayer falls off generation , there is typical cytopathic effect (CPE) in seine phenomenon, and is passaged to the 10th generation CPE stabilization (Fig. 3), and normal CSC Cell has no any variation.
The CyHV-2 cell culture DNA of different subculture is extracted, PCR detection is carried out, is obtained by two-wheeled PCR amplification The segment of 357bp, it is (Fig. 4) in the same size with the amplified band of positive control, as a result it is determined as the positive.
The CyHV-2 virus of a large amount of maturations can be observed in the CSC cell that the 7th generation CyHV-2 is infected by transmission electron microscope observing Particle illustrates that CyHV-2 has good biological activity (Fig. 5) in CSC cell, further demonstrates the present invention and is established Hybridized prussian carp myeloid tissue cell line to virus sensibility, can be used for virus separation, culture and detection.Meanwhile it can make For the cell model for studying carp herpesvirusⅡtype biological characteristics, the vaccine of carp herpesvirusⅡtype is prepared.
Above description has shown and described several preferred embodiments of invention, but as previously described, it should be understood that invention is not It is confined to form disclosed herein, should not be regarded as an exclusion of other examples, and can be used for various other combinations, modification And environment, and can be carried out within that scope of the inventive concept describe herein by the above teachings or related fields of technology or knowledge Change.And changes and modifications made by those skilled in the art do not depart from the spirit and scope of invention, then it all should be in the appended power of invention In the protection scope that benefit requires.
Sequence table
<110>Chengdu Tianbang Biological Products Co., Ltd. of Zhejiang Institute of Fresh Water Aquatic Products
<120>a kind of hybridized prussian carp myeloid tissue cell line and its construction method are applied with it
<130> 2018
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 26
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 1
ggacttgcga agagtttgat ttctac 26
<210> 2
<211> 22
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 2
ccatagtcac catcgtctca tc 22

Claims (9)

1. a kind of hybridized prussian carp myeloid tissue cell line (Spinal cord tissue cell lines of Carassius Auratus gibelio, CSC), which is characterized in that its deposit number is CCTCC NO:C2018211.
2. the construction method of hybridized prussian carp myeloid tissue described in claim 1 cell line, which is characterized in that including following step It is rapid:
The processing of step 1, myeloid tissue: taking out hybridized prussian carp myeloid tissue under aseptic condition, aseptic process is 30~60mm3's Tissue block is put into the culture dish of the culture solution containing L15;
Step 2, originally culture: the tissue block in step 1 is equably put into T25 Tissue Culture Flask, puts the one side of tissue block Upward, 3ml culture solution is added in culture bottle slowly culture bottle side comes overnight, so that tissue block is infiltrated culture solution, then will have Upward, during which irregularly Tissue Culture Flask is just being set training once up to organizing block edge to grow cell to the one side of tissue block by operation It supports, replacement culture solution is primary within every 2~3 days;
Step 3, secondary culture: after originally culture hybridized prussian carp myeloid tissue cell grows up to single layer, tryptic digestive juice is added Digestion 1~2 minute is stood, has hanged cell with culture solution, secondary culture is carried out in such a way that 1 bottle passes 2 bottles, is formed again to cell After single layer, secondary culture next time is carried out according to the secondary culture method of above-mentioned cell, obtains a kind of hybridized prussian carp spinal cord group The cell line CSC knitted.
3. construction method according to claim 2, which is characterized in that the hybridized prussian carp myeloid tissue in the step 1 Cell L15 culture solution be containing 10~20%V/V fetal calf serum, 100U/ml penicillin, 100 μ g/ml streptomysins, pH value 7.0~ 7.4 culture solution.
4. construction method according to claim 2, which is characterized in that the tryptose of the cell passage in the step 3 Enzymic digestion liquid is 0.25%W/V trypsase-EDTA digestive juice.
5. construction method according to claim 2, which is characterized in that cell culture in step 2 and step 3, passage Temperature is 23~25 DEG C, pH value 7.0~7.4.
6. hybridized prussian carp myeloid tissue cell line described in claim 1 separates, in culture and detection in carp herpesvirusⅡtype Using.
7. application according to claim 7, which is characterized in that the carp herpesvirusⅡtype is carp herpesvirusⅡtype point From strain.
8. application of the hybridized prussian carp myeloid tissue cell line described in claim 1 in the vaccine of preparation carp herpesvirusⅡtype.
9. application according to claim 7, which is characterized in that the carp herpesvirusⅡtype is carp herpesvirusⅡtype point From strain.
CN201811231823.XA 2018-10-22 2018-10-22 Carassius auratus gibelio spinal cord tissue cell line as well as construction method and application thereof Active CN109294974B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811231823.XA CN109294974B (en) 2018-10-22 2018-10-22 Carassius auratus gibelio spinal cord tissue cell line as well as construction method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811231823.XA CN109294974B (en) 2018-10-22 2018-10-22 Carassius auratus gibelio spinal cord tissue cell line as well as construction method and application thereof

Publications (2)

Publication Number Publication Date
CN109294974A true CN109294974A (en) 2019-02-01
CN109294974B CN109294974B (en) 2022-09-13

Family

ID=65158398

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811231823.XA Active CN109294974B (en) 2018-10-22 2018-10-22 Carassius auratus gibelio spinal cord tissue cell line as well as construction method and application thereof

Country Status (1)

Country Link
CN (1) CN109294974B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110305844A (en) * 2019-03-06 2019-10-08 成都天邦生物制品有限公司 A kind of crucian myeloid tissue cell line and its application
CN110893235A (en) * 2019-11-13 2020-03-20 浙江省淡水水产研究所 Crucian carp hematopoietic organ necrosis inactivated vaccine and preparation method thereof
CN111411087A (en) * 2020-03-16 2020-07-14 中国水产科学研究院长江水产研究所 Cyprinus carpioides herpesvirus II type low virulent strain and application thereof
CN113755438A (en) * 2021-10-11 2021-12-07 浙江省淡水水产研究所 Mandarin fish spinal cord tissue cell line and construction method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101820905A (en) * 2007-08-28 2010-09-01 列日大学 Recombinant koi herpesvirus (KHV) or cyprinid herpesvirus 3 (CyHV-3) and vaccine for the prevention of disease caused by KHV/CyHV-3 in cyprinus carpio carpio or cyprinus carpio koi
CN103667176A (en) * 2013-12-09 2014-03-26 中国水产科学研究院长江水产研究所 Carassius auratus gibelio brain tissue cell line sensitive to cyprinid herpesvirus II, and establishing method and application thereof
CN104762252A (en) * 2015-04-27 2015-07-08 上海海洋大学 Grass goldfish pelvic fin cell line constructing method
CN105543162A (en) * 2015-11-27 2016-05-04 深圳出入境检验检疫局动植物检验检疫技术中心 Crucian brain tissue cell line and application thereof
CN108546672A (en) * 2018-04-20 2018-09-18 上海海洋大学 A kind of construction method of hybridized prussian carp caudal fin cell system and its application

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101820905A (en) * 2007-08-28 2010-09-01 列日大学 Recombinant koi herpesvirus (KHV) or cyprinid herpesvirus 3 (CyHV-3) and vaccine for the prevention of disease caused by KHV/CyHV-3 in cyprinus carpio carpio or cyprinus carpio koi
CN103667176A (en) * 2013-12-09 2014-03-26 中国水产科学研究院长江水产研究所 Carassius auratus gibelio brain tissue cell line sensitive to cyprinid herpesvirus II, and establishing method and application thereof
CN104762252A (en) * 2015-04-27 2015-07-08 上海海洋大学 Grass goldfish pelvic fin cell line constructing method
CN105543162A (en) * 2015-11-27 2016-05-04 深圳出入境检验检疫局动植物检验检疫技术中心 Crucian brain tissue cell line and application thereof
CN108546672A (en) * 2018-04-20 2018-09-18 上海海洋大学 A kind of construction method of hybridized prussian carp caudal fin cell system and its application

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DAVISON, AJ: "Comparative Genomics of Carp Herpesviruses", 《JOURNAL OF VIROLOGY》 *
JIE MA: "Establishment of a novel and highly permissive cell line for the efficient replication of cyprinid herpesvirus 2 (CyHV-2)", 《VETERINARY MICROBIOLOGY》 *
JINXU: "Cyprinid herpesvirus 2 infection emerged in cultured gibel carp, Carassius auratus gibelio in China", 《VETERINARY MICROBIOLOGY》 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110305844A (en) * 2019-03-06 2019-10-08 成都天邦生物制品有限公司 A kind of crucian myeloid tissue cell line and its application
CN110305844B (en) * 2019-03-06 2022-12-23 成都史纪生物制药有限公司 Crucian spinal cord tissue cell line and application thereof
CN110893235A (en) * 2019-11-13 2020-03-20 浙江省淡水水产研究所 Crucian carp hematopoietic organ necrosis inactivated vaccine and preparation method thereof
CN110893235B (en) * 2019-11-13 2023-10-24 浙江省淡水水产研究所 Inactivated vaccine for crucian hematopoietic necrosis and preparation method thereof
CN111411087A (en) * 2020-03-16 2020-07-14 中国水产科学研究院长江水产研究所 Cyprinus carpioides herpesvirus II type low virulent strain and application thereof
CN111411087B (en) * 2020-03-16 2021-03-23 中国水产科学研究院长江水产研究所 Cyprinus carpioides herpesvirus II type low virulent strain and application thereof
CN113755438A (en) * 2021-10-11 2021-12-07 浙江省淡水水产研究所 Mandarin fish spinal cord tissue cell line and construction method and application thereof
CN113755438B (en) * 2021-10-11 2023-08-08 浙江省淡水水产研究所 Mandarin fish spinal cord tissue cell line and construction method and application thereof

Also Published As

Publication number Publication date
CN109294974B (en) 2022-09-13

Similar Documents

Publication Publication Date Title
CN103667176B (en) Carassius auratus gibelio brain tissue cell line sensitive to cyprinid herpesvirus II, and establishing method and application thereof
CN109294974A (en) A kind of hybridized prussian carp myeloid tissue cell line and its construction method are applied with it
CN109609460B (en) A kind of human glioma cell line and its method for building up and application
CN105925523B (en) A kind of Squaliobarbus curriculus fin ray cell line and its method for building up and application
CN113025574B (en) Micropterus salmoides brain cell line and application thereof
CN105483075B (en) A kind of culture medium and method for cultivating Urechis uniconctus trochophore cell line
CN104152403B (en) A kind of method that establishing goose embryonic epithelium cell line and the goose embryonic epithelium cell line of foundation
CN109161515A (en) The isolated culture method of megalobrama amblycephala primary hepatocyte
CN104818241B (en) Epinephelus lanceolatus fish-skin skin tissue cell line and its construction method
CN103232971A (en) A method for B lymphocyte transformation by EB virus (Epstein-barr virus) for elite ice and snow athletes
CN105441386A (en) Culture and identification method for very small porcine embryonic-like stem cells
CN109207422B (en) European eel kidney cell line EK and application thereof
CN110305844A (en) A kind of crucian myeloid tissue cell line and its application
CN108774630A (en) A kind of primary culture method of Microhyla ornata Skeletal Muscle Cell
CN113755438B (en) Mandarin fish spinal cord tissue cell line and construction method and application thereof
CN102120983B (en) Separation and culture method of epidermal stem cells of Beijing ducks
CN107541484A (en) Diploid red crucian caudal fin cell system 2nFC and its construction method and application
CN110295137B (en) Channa argus kidney cell line and construction method and application thereof
CN107156107A (en) A kind of human umbilical cord mesenchymal stem cells cryoprotective agent comprising rhMG53
CN106906177A (en) A kind of naked mole interstitial glands is isolated and purified and cultural method
CN116836912B (en) Lateolabrax japonicus kistrodon cell line and construction method and application thereof
CN115161285B (en) Immortalized Holstein male calf small intestine epithelial cell line and construction method and application thereof
CN103333918B (en) A kind of method improving porcine clone embryos ectogenesis efficiency
CN117904032B (en) Sea bass fin line cell line and application thereof
RU2506310C1 (en) STRAIN OF DIPLOID CELLS OF SYNOVIAL MEMBRANE OF YOUNG PIG Sus scrofa, USED FOR VIROLOGY RESEARCH

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Shen Jinyu

Inventor after: Cao Zheng

Inventor after: Pan Xiaoyi

Inventor after: Yao Jiabin

Inventor after: Lin Lingyun

Inventor after: Yin Wenlin

Inventor after: Liu Yihan

Inventor before: Shen Jinyu

Inventor before: Xing Gang

Inventor before: Yue Fengxiong

Inventor before: Zhou Tao

Inventor before: Huang Jie

Inventor before: Cao Zheng

Inventor before: Pan Xiaoyi

Inventor before: Xia Yanchun

Inventor before: Yao Jiabin

Inventor before: Lin Lingyun

Inventor before: Yin Wenlin

Inventor before: Liu Yihan

Inventor before: Lu Yuxiao

CB03 Change of inventor or designer information
TR01 Transfer of patent right

Effective date of registration: 20221207

Address after: No. 999, Hangchang Bridge South Road, Huzhou City, Zhejiang Province 313098

Patentee after: ZHEJIANG INSTITUTE OF FRESH WATER FISHERIES

Address before: 313001 No. 999, hangchangqiao South Road, Wuxing District, Huzhou City, Zhejiang Province

Patentee before: ZHEJIANG INSTITUTE OF FRESH WATER FISHERIES

Patentee before: CHENGDU TECBOND BIOLOGICAL PRODUCTS CO.,LTD.

TR01 Transfer of patent right